Impfung gegen SARS-CoV-2 bei Krebspatienten

Patients with cancer are at an increased risk to suffer severe coronavirus disease 2019 (COVID-19). Therefore, specific preventative measures including COVID-19 vaccines are especially important. Both anticancer therapies and the underlying malignancy itself can lead to significant immunosuppression...

Descripción completa

Detalles Bibliográficos
Autores principales: von Lilienfeld-Toal, Marie, Rieger, Christina, Giesen, Nicola, Wörmann, Bernhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Außer der Reihe
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127852/
https://www.ncbi.nlm.nih.gov/pubmed/34025046
http://dx.doi.org/10.1007/s00761-021-00972-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127852/
https://www.ncbi.nlm.nih.gov/pubmed/34025046
http://dx.doi.org/10.1007/s00761-021-00972-1

Ejemplares similares